Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.745 USD | +3.20% | -0.90% | +41.49% |
May. 06 | Sector Update: Health Care Stocks Higher in Late Afternoon Trading | MT |
May. 06 | Lyell Immunopharma Shares Rise After Q1 Net Loss Narrows | MT |
Financials (USD)
Sales 2024 * | 2K | Sales 2025 * | 5M | Capitalization | 700M |
---|---|---|---|---|---|
Net income 2024 * | -222M | Net income 2025 * | -253M | EV / Sales 2024 * | 289,343 x |
Net cash position 2024 * | 121M | Net cash position 2025 * | 471M | EV / Sales 2025 * | 45.8 x |
P/E ratio 2024 * |
-3.19
x | P/E ratio 2025 * |
-3.06
x | Employees | 224 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.33% |
1 day | +3.20% | ||
1 week | -0.90% | ||
Current month | -0.90% | ||
1 month | +26.50% | ||
3 months | -5.99% | ||
6 months | +58.67% | ||
Current year | +41.49% |
Managers | Title | Age | Since |
---|---|---|---|
Lynn Seely
CEO | Chief Executive Officer | 65 | 21-04-30 |
Charles Newton
DFI | Director of Finance/CFO | 53 | 21-01-31 |
Stephen Hill
COO | Chief Operating Officer | 53 | 19-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lynn Seely
CEO | Chief Executive Officer | 65 | 21-04-30 |
Robert Nelsen
BRD | Director/Board Member | 60 | 18-08-31 |
Otis Brawley
BRD | Director/Board Member | 64 | 21-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.02% | 1,487 M€ | +7.77% | - | |
0.01% | 234 M€ | +8.48% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2.77 | +4.14% | 649,316 |
24-05-30 | 2.66 | +3.91% | 502,464 |
24-05-29 | 2.56 | -6.91% | 598,718 |
24-05-28 | 2.75 | -0.72% | 295,942 |
24-05-24 | 2.77 | +2.21% | 586,576 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.49% | 700M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- LYEL Stock